CGA CPA - Telo Genomics Chief Officer
| TDSGF Stock | USD 0.09 0.02 34.29% |
Insider
CGA CPA is Chief Officer of Telo Genomics Corp
| Phone | 416 673 8487 |
| Web | https://www.telodx.com |
Telo Genomics Management Efficiency
The company has return on total asset (ROA) of (0.454) % which means that it has lost $0.454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7783) %, meaning that it generated substantial loss on money invested by shareholders. Telo Genomics' management efficiency ratios could be used to measure how well Telo Genomics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Marcel Konrad | Caredx Inc | 48 | |
| Sri Kalluri | EXACT Sciences | N/A | |
| Mickey MD | Caredx Inc | N/A | |
| Jorge Garces | EXACT Sciences | 52 | |
| Olesya CPA | Natera Inc | N/A | |
| Susan Tousi | Illumina | 55 | |
| Sasha MBA | Caredx Inc | 38 | |
| Abraham Esq | Caredx Inc | 51 | |
| Scott Ericksen | Illumina | 51 | |
| Marica Grskovic | Caredx Inc | N/A | |
| Everett Cunningham | EXACT Sciences | 58 | |
| Alexander MD | Illumina | 47 | |
| Stephanie Campos | Illumina | N/A | |
| Erin Smith | Twist Bioscience Corp | N/A | |
| Kevin Pegels | Illumina | 56 | |
| LLM LLM | Natera Inc | 55 | |
| Jonathan MEng | Natera Inc | 51 | |
| Siyuan Chen | Twist Bioscience Corp | N/A | |
| Aaron Sato | Twist Bioscience Corp | N/A | |
| Carissa Rollins | Illumina | 54 | |
| Megan Jones | EXACT Sciences | N/A | |
Management Performance
| Return On Equity | -0.78 | |||
| Return On Asset | -0.45 |
Telo Genomics Corp Leadership Team
Elected by the shareholders, the Telo Genomics' board of directors comprises two types of representatives: Telo Genomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telo. The board's role is to monitor Telo Genomics' management team and ensure that shareholders' interests are well served. Telo Genomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telo Genomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sabine Mai, Member Founder | ||
| Kristan Weinberg, Chief Officer | ||
| CGA CPA, Chief Officer |
Telo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Telo Genomics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.45 | |||
| Current Valuation | 13.73 M | |||
| Shares Outstanding | 59.42 M | |||
| Shares Owned By Insiders | 6.52 % | |||
| Shares Owned By Institutions | 1.83 % | |||
| Price To Earning | (0.67) X | |||
| Price To Book | 10.46 X | |||
| EBITDA | (2.05 M) | |||
| Net Income | (2.11 M) |
Currently Active Assets on Macroaxis
Other Information on Investing in Telo OTC Stock
Telo Genomics financial ratios help investors to determine whether Telo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telo with respect to the benefits of owning Telo Genomics security.